Z Orthop Unfall 2018; 156(01): 21-29
DOI: 10.1055/s-0043-116942
Georg Thieme Verlag KG Stuttgart · New York

Therapeutische Optionen beim periprothetischen Infekt des Schultergelenks

Therapy of Periprosthetic Shoulder Infection
Bernd Fink
1   Klinik für Endoprothetik, Allgemeine und Rheumaorthopädie, Orthopädische Klinik Markgrönigen
2   Orthopädische Universitätsklinik Hamburg-Eppendorf
Florian Sevelda
1   Klinik für Endoprothetik, Allgemeine und Rheumaorthopädie, Orthopädische Klinik Markgrönigen
3   Orthopädische Universitätsklinik Wien
› Author Affiliations
Further Information

Publication History

Publication Date:
23 August 2017 (online)


Für die Behandlung von periprothetischen Infektionen von Schulterendoprothesen existieren verschiedene therapeutische Konzepte. Bei akuten periprothetischen Infektionen kann das Implantat belassen werden, alle mobilen Teile (Inlay) sollten bei einem offenen Débridement gewechselt werden und Spülungen mit antibakteriellen Lösungen wie Octinedin oder Polyhexanid durchgeführt werden. Bei Spätinfektionen sind die therapeutischen Optionen nach der Entfernung des infizierten Implantats: Einlage eines permanent verbleibenden Spacers, die Resektionsarthroplastik, einzeitige und zweizeitige Wechsel mit und ohne temporären Spacer. Die funktionellen Ergebnisse sind beim einzeitigen Wechsel am besten und die Eradikationsrate vergleichbar mit derjenigen beim zweizeitigen Wechsel. Voraussetzung für den einzeitigen Wechsel ist die Identifizierung des Keimes, um zielgerichtete Antibiotika in den Zement beizumischen und systemisch zu verabreichen.


There are several therapeutic options for the treatment of periprosthetic joint infections of shoulder arthroplasties. In acute infections, the implant can remain in place with open debridement, septic lavage with antibacterial solutions such as octinedine or polyhexanide solution and exchange of all mobile components. In late infections, the therapeutic options after removal of the infected implant are: permanent spacer, resection arthroplasty, one stage revision and two stage revision with or without a temporary spacer. The functional results are best for one stage revisions, with similar prosthetic survival to two stage revisions. For one stage revisions, the microorganism has to be identified prior to revision surgery, in order to use targeted antibiotics locally in the cement, and systemically.

  • Literatur

  • 1 Richards J, Inacio MC, Beckett M. et al. Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty. Clin Orthop Relat Res 2014; 472: 2809-2815
  • 2 Beekman PD, Katusic D, Berghs BM. et al. One-stage revision for patients with a chronically infected reverse total shoulder replacement. J Bone Joint Surg Br 2010; 92: 817-822
  • 3 Hudek R, Gohlke F. [Endoprosthesis infections of the shoulder: diagnosis and therapy algorithm]. Orthopade 2013; 42: 552-559
  • 4 Padegimas EM, Maltenfort M, Ramsey ML. et al. Periprosthetic shoulder infection in the United States: incidence and economic burden. J Shoulder Elbow Surg 2015; 24: 741-746
  • 5 Singh JA, Sperling JW, Schleck C. et al. Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective. J Shoulder Elbow Surg 2012; 21: 1534-1541
  • 6 Wirth MA, Rockwood jr. CA. Complications of shoulder arthroplasty. Clin Orthop Relat Res 1994; 307: 47-69
  • 7 Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78: 512-523
  • 8 Aboltins CA, Dowsey MM, Buising KL. et al. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect 2011; 17: 862-867
  • 9 Berdal JE, Skramm I, Mowinckel P. et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005; 11: 843-845
  • 10 Martinez-Pastor JC, Munoz-Mahamud E, Vilchez F. et al. Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother 2009; 53: 4772-4777
  • 11 Zimmerli W, Widmer AF, Blatter M. et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-1541
  • 12 Dennison T, Alentorn-Geli E, Assenmacher AT. et al. Management of acute or late hematogenous infection after shoulder arthroplasty with irrigation, debridement, and component retention. J Shoulder Elbow Surg 2017; 26: 73-78
  • 13 Franceschini V, Chillemi C. Periprosthetic shoulder infection. Open Orthop J 2013; 7: 243-249
  • 14 Hackett jr. DJ, Crosby LA. Evaluation and treatment of the infected shoulder arthroplasty. Bull Hosp Jt Dis 2013; 71 (Suppl. 02) S88-S93
  • 15 Byren I, Bejon P, Atkins BL. et al. One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63: 1264-1271
  • 16 Choi HR, von Knoch F, Zurakowski D. et al. Can implant retention be recommended for treatment of infected TKA?. Clin Orthop Relat Res 2011; 469: 961-969
  • 17 Sperling JW, Kozak TK, Hanssen AD. et al. Infection after shoulder arthroplasty. Clin Orthop Relat Res 2001; 382: 206-216
  • 18 Trampuz A, Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs 2005; 6: 185-190
  • 19 Abdi-Ali A, Mohammadi-Mehr M, Agha Alaei Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents 2006; 27: 196-200
  • 20 Widmer AF, Wiestner A, Frei R. et al. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35: 741-746
  • 21 Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654
  • 22 Yassien M, Khardori N, Ahmedy A. et al. Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob Agents Chemother 1995; 39: 2262-2268
  • 23 Diekema DJ, Pfaller MA, Schmitz FJ. et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001; 32 (Suppl. 02) S114-S132
  • 24 Nimmo GR, Bell JM, Mitchell D. et al. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989–1999. Microb Drug Resist 2003; 9: 155-160
  • 25 Zervos MJ, Hershberger E, Nicolau DP. et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000. Clin Infect Dis 2003; 37: 1643-1648
  • 26 Fink B, Schuster P, Schwenninger C. et al. A standardized regimen for the treatment of acute postoperative infections and acute hematogenous infections associated with hip and knee arthroplasties. J Arthroplasty 2017; 32: 1255-1261
  • 27 Coste JS, Reig S, Trojani C. et al. The management of infection in arthroplasty of the shoulder. J Bone Joint Surg Br 2004; 86: 65-69
  • 28 George DA, Volpin A, Scarponi S. et al. Does exchange arthroplasty of an infected shoulder prosthesis provide better eradication rate and better functional outcome, compared to a permanent spacer or resection arthroplasty? A systematic review. BMC Musculoskelet Disord 2016; 17: 52
  • 29 Chastre J, Luyt CE, Combes A. et al. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit. Clin Infect Dis 2006; 43 (Suppl. 02) S75-S81
  • 30 Romano CL, Borens O, Monti L. et al. What treatment for periprosthetic shoulder infection? Results from a multicentre retrospective series. Int Orthop 2012; 36: 1011-1017
  • 31 Debeer P, Plasschaert H, Stuyck J. Resection arthroplasty of the infected shoulder: a salvage procedure for the elderly patient. Acta Orthop Belg 2006; 72: 126-130
  • 32 Verhelst L, Stuyck J, Bellemans J. et al. Resection arthroplasty of the shoulder as a salvage procedure for deep shoulder infection: does the use of a cement spacer improve outcome?. J Shoulder Elbow Surg 2011; 20: 1224-1233
  • 33 Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res 2004; 427: 79-85
  • 34 Fink B, Grossmann A, Fuerst M. et al. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res 2009; 467: 1848-1858
  • 35 Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 1995; 77: 1576-1588
  • 36 Hsieh PH, Chang YH, Chen SH. et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 2006; 24: 1615-1621
  • 37 Bertazzoni Minelli E, Benini A, Magnan B. et al. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 2004; 53: 329-334
  • 38 Fink B, Vogt S, Reinsch M. et al. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 2011; 469: 3141-3147
  • 39 Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 1998; 13: 331-338
  • 40 Anagnostakos K, Kelm J, Regitz T. et al. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater 2005; 72: 373-378
  • 41 Baleani M, Persson C, Zolezzi C. et al. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 2008; 23: 1232-1238
  • 42 Ensing GT, van Horn JR, van der Mei HC. et al. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res 2008; 466: 1492-1498
  • 43 Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996; 11: 939-944
  • 44 Simpson PM, Dall GF, Breusch SJ. et al. [In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements]. Orthopade 2005; 34: 1255-1262
  • 45 Magnan B, Bondi M, Vecchini E. et al. A preformed antibiotic-loaded spacer for treatment for septic arthritis of the shoulder. Musculoskelet Surg 2014; 98: 15-20
  • 46 Haddad S, Corona PS, Reverte MM. et al. Antibiotic-impregnated cement spacer as a definitive treatment for post-arthroscopy shoulder destructive osteomyelitis: case report and review of literature. Strategies Trauma Limb Reconstr 2013; 8: 199-205
  • 47 Li FL, Jiang CY, Lu Y. et al. [Efficacy analysis of two-stage reverse total shoulder arthroplasty for treating postoperative deep infection after surgeries for proximal humeral fractures]. Beijing Da Xue Xue Bao 2016; 48: 263-267
  • 48 Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection. A comparison-group study. J Bone Joint Surg Am 2000; 82-A: 1552-1557
  • 49 Cui Q, Mihalko WM, Shields JS. et al. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am 2007; 89: 871-882
  • 50 Hoell S, Moeller A, Gosheger G. et al. Two-stage revision arthroplasty for periprosthetic joint infections: what is the value of cultures and white cell count in synovial fluid and CRP in serum before second stage reimplantation?. Arch Orthop Trauma Surg 2016; 136: 447-452
  • 51 Ince A, Seemann K, Frommelt L. et al. One-stage exchange shoulder arthroplasty for peri-prosthetic infection. J Bone Joint Surg Br 2005; 87: 814-818
  • 52 Klatte TO, Junghans K, Al-Khateeb H. et al. Single-stage revision for peri-prosthetic shoulder infection: outcomes and results. Bone Joint J 2013; 95-B: 391-395
  • 53 Moroder P, Gerhardt C, Renz N. et al. Diagnostik und Management des Endoprotheseninfekts am Schultergelenk. Obere Extremität 2016; 11: 78-87
  • 54 Cuff DJ, Virani NA, Levy J. et al. The treatment of deep shoulder infection and glenohumeral instability with debridement, reverse shoulder arthroplasty and postoperative antibiotics. J Bone Joint Surg Br 2008; 90: 336-342
  • 55 Nelson GN, Davis DE, Namdari S. Outcomes in the treatment of periprosthetic joint infection after shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg 2016; 25: 1337-1345
  • 56 Marcheggiani Muccioli GM, Huri G, Grassi A. et al. Surgical treatment of infected shoulder arthroplasty. A systematic review. Int Orthop 2017; 41: 823-830
  • 57 Hsieh PH, Shih CH, Chang YH. et al. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 2004; 86-A: 1989-1997
  • 58 Hsieh PH, Shih CH, Chang YH. et al. Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg Br 2005; 87: 770-775
  • 59 Fink B. Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts. Int J Med Sci 2009; 6: 287-295
  • 60 Saper D, Capiro N, Ma R. et al. Management of Propionibacterium acnes infection after shoulder surgery. Curr Rev Musculoskelet Med 2015; 8: 67-74
  • 61 Parvizi J, Gehrke T, Chen AF. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013; 95-B: 1450-1452
  • 62 Braman JP, Sprague M, Bishop J. et al. The outcome of resection shoulder arthroplasty for recalcitrant shoulder infections. J Shoulder Elbow Surg 2006; 15: 549-553
  • 63 Rispoli DM, Sperling JW, Athwal GS. et al. Pain relief and functional results after resection arthroplasty of the shoulder. J Bone Joint Surg Br 2007; 89: 1184-1187
  • 64 Ghijselings S, Stuyck J, Debeer P. Surgical treatment algorithm for infected shoulder arthroplasty: a retrospective analysis of 17 cases. Acta Orthop Belg 2013; 79: 626-635
  • 65 Weber P, Utzschneider S, Sadoghi P. et al. Management of the infected shoulder prosthesis: a retrospective analysis and review of the literature. Int Orthop 2011; 35: 365-373
  • 66 Themistocleous G, Zalavras C, Stine I. et al. Prolonged implantation of an antibiotic cement spacer for management of shoulder sepsis in compromised patients. J Shoulder Elbow Surg 2007; 16: 701-705
  • 67 Stine IA, Lee B, Zalavras CG. et al. Management of chronic shoulder infections utilizing a fixed articulating antibiotic-loaded spacer. J Shoulder Elbow Surg 2010; 19: 739-748
  • 68 Mahure SA, Mollon B, Yu S. et al. Definitive Treatment of Infected Shoulder Arthroplasty With a Cement Spacer. Orthopedics 2016; 39: e924-e930
  • 69 Mileti J, Sperling JW, Cofield RH. Reimplantation of a shoulder arthroplasty after a previous infected arthroplasty. J Shoulder Elbow Surg 2004; 13: 528-531
  • 70 Seitz jr WH, Damacen H. Staged exchange arthroplasty for shoulder sepsis. J Arthroplasty 2002; 17 (4 Suppl. 1): 36-40
  • 71 Strickland JP, Sperling JW, Cofield RH. The results of two-stage re-implantation for infected shoulder replacement. J Bone Joint Surg Br 2008; 90: 460-465
  • 72 Buchalter DB, Mahure SA, Mollon B. et al. Two-stage revision for infected shoulder arthroplasty. J Shoulder Elbow Surg 2017; 26: 939-947